Cargando…
Select octogenarians with stage IIIa non–small cell lung cancer can benefit from trimodality therapy
OBJECTIVES: Currently, more than 36% of patients diagnosed with lung cancer are 75 years of age or older. Management of stage IIIA cancer is variable, especially for octogenarians who might not be offered surgery because of questionable benefit. In this study we investigated the outcomes of definiti...
Autores principales: | Tang, Andrew, Feczko, Andrew, Murthy, Sudish C., Raja, Siva, Bribriesco, Alejandro, Schraufnagel, Dean, Ahmad, Usman, Raymond, Daniel P., Sudarshan, Monisha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390188/ https://www.ncbi.nlm.nih.gov/pubmed/36004217 http://dx.doi.org/10.1016/j.xjon.2022.01.022 |
Ejemplares similares
-
Coronavirus disease 2019 (COVID-19): Team preparation and approach to tracheostomy
por: Bribriesco, Alejandro C., et al.
Publicado: (2020) -
Successful management of aorto-conduit fistula after esophagectomy: Tips and tricks to avoid catastrophe
por: Feczko, Andrew F., et al.
Publicado: (2021) -
Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer—results from a retrospective analysis
por: Joosten, Pieter J M, et al.
Publicado: (2021) -
The Accuracy of Clinical Staging of Stage I-IIIa Non-Small Cell Lung Cancer: An Analysis Based on Individual Participant Data
por: Navani, Neal, et al.
Publicado: (2019) -
Surgical markup in lung cancer resection, 2015-2020
por: Robinson, Eric, et al.
Publicado: (2023)